Showing results (61-70 of 635) with videos related to
Sort By:
Pageof 64
Lancet (London, England)|October 16, 1976
The neurology of vitamin B12 deficiency. Metabolic mechanismsE H ReynoldsBrain Research|December 4, 2001
6-Hydroxydopamine-lesioning of the nigrostriatal pathway in rats alters basal ganglia mRNA for copper, zinc- and manganese-superoxide dismutase, but not glutathione peroxidaseG Kunikowska, P JennerAmerican Journal of Clinical Pathology|May 1, 1990
Variability in the fibrinogen and von Willebrand factor content of cryoprecipitate. Implications for reducing donor exposureM Hoffman, P JennerEuropean Journal of Neurology|January 7, 2012
Moving from continuous dopaminergic stimulation to continuous drug delivery in the treatment of Parkinson's diseaseO Gershanik, P JennerEuropean Journal of Pharmacology|August 1, 1975
The influence of piribedil (ET495) on components of locomotor activityP Jenner, C D MarsdenJournal of the Neurological Sciences|March 1, 1993
Reduction in cortical 5-HT3 binding sites following a unilateral 6-hydroxydopamine lesion of the medial forebrain bundle in ratsL Cicin-Sain, P JennerAdvances in Biochemical Psychopharmacology|January 1, 1982
The mode of action of sulpiride as an atypical antidepressant agentP Jenner, C D MarsdenNeuroscience Letters|May 2, 2000
Dysfunction of rat forebrain astrocytes in culture alters cytokine and neurotrophic factor releaseK S McNaught, P JennerJournal of Neurochemistry|December 3, 1999
Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-culturesK S McNaught, P JennerPageof 64